EMPE Diagnostics

  • First investment year: 2018
  • Fund: Stockholm
  • Business sector: Life Science

EMPE develops diagnostic solutions for infectious diseases focusing on tuberculosis and sexually transmitted infections. EMPE's rapid tests identifies bacteria or virus and their antimicrobial resistances within 70 min. EMPE’s diagnostic solutions brings the diagnosis time from months to minutes at an affordable cost that can reduce the hidden danger of antibiotic resistance.